Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Recurrence × aldesleukin × Clear all

Phase

Status

Completed 7 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 25 Neoplasm Metastasis 15 Skin Neoplasms 8 Leukemia, Myeloid, Acute 7 Ovarian Neoplasms 6 Kidney Neoplasms 6 Carcinoma, Renal Cell 6 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Lymphoma, Non-Hodgkin 4 Breast Neoplasms 4 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Lymphoma 3 Lung Neoplasms 3 Leukemia 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Triple Negative Breast Neoplasms 2 Sezary Syndrome 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2

Interventions

Cyclophosphamide 21 Dexamethasone 19 Rituximab 16 Cytarabine 16 fludarabine 10 Methotrexate 10 Gemcitabine 10 Bortezomib 10 Lenalidomide 9 Filgrastim 9 Etoposide 8 pembrolizumab 7 Vincristine 7 Paclitaxel 7 Cyclosporine 7 carfilzomib 6 Topotecan 6 Temozolomide 6 Docetaxel 6 Calcium Dobesilate 6 Antilymphocyte Serum 6 pomalidomide 5 fludarabine phosphate 5 Radiotherapy 5 Peripheral Blood Stem Cell Transplantation 5 Pemetrexed 5 Mitoxantrone 5 Granulocyte Colony-Stimulating Factor 5 Doxorubicin 5 Azacitidine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04347616 2026-03-16

NK4AML

Radboud University Medical Center

Phase 1/2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡